Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
WST
BUYFLAGWest Pharmaceutical Services, Inc. · Healthcare · United States · $23.1B · Avg Vol: $287M/d
West Pharmaceutical has strong quality Q76 and momentum M79 with a buyback retiring 2.51% of shares, but value at V18 is well below the calibrated floor, so stage one fails.
COMPANY DESCRIPTION
West Pharmaceutical Services is a global leader in designing and manufacturing high-quality containment and delivery systems for injectable drugs and other healthcare products, including stoppers, seals, and syringe components. The company's competitive moat is built upon its critical position as a trusted partner to pharmaceutical companies, extensive regulatory expertise, and proprietary technologies, which create high switching costs for drug packaging. West is a niche market leader, integral to the biopharmaceutical supply chain.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.9B | 2.9B | 2.9B | 3.1B | 2.1% | 3.2B | 3.4B | 3.6B | 7.8% |
| EPS | 7.87 | 7.98 | 6.75 | 6.83 | -4.6% | 7.36 | 8.35 | 9.26 | 16.4% |
| Shares | 74.1M | 73.5M | 72.3M | 72.0M | -2.8% | 70.6M | — | — | — |
| Debt | 317.9M | 309.0M | 302.3M | 321.1M | 0.3% | 321.0M | — | — | — |
| Equity | 2.7B | 2.9B | 2.7B | 3.2B | 5.8% | — | — | — | — |
| Op CF | 724.0M | 776.5M | 653.4M | 754.8M | 1.4% | 715.3M | — | — | — |
| Inv CF | -288.2M | -368.7M | -378.7M | -285.9M | — | — | — | — | — |
| Fin CF | -293.6M | -459.6M | -622.6M | -185.1M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of WST are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| WST | West Pharmaceutical Services, Inc.(you) | $23.1B | 77 | BUY |
| RMD | ResMed Inc. | $28.3B | 78 | BUY |
| SOLV | Solventum Corporation | $13.5B | 78 | BUY |
| BDX.MX | Becton, Dickinson and Company | $41.3B | 74 | BUY |
| BAX | Baxter International Inc. | $11.6B | 69 | BUY |
| ATR | AptarGroup, Inc. | $8.4B | 74 | BUY |
| ALGN | Align Technology, Inc. | $12.0B | 93 | STRONG BUY |
| COO | The Cooper Companies, Inc. | $13.7B | 54 | HOLD |
| MMSI | Merit Medical Systems, Inc. | $4.4B | 78 | BUY |
| TFX | Teleflex Incorporated | $5.8B | 70 | BUY |
Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.7%